Title: Further in vivo data demonstrating the efficacy of our novel compound OH14 in targeting triple negative breast cancer stem cells
Funder
Team Verrico
Principal Investigator
Project Details
Net value award figure for Cardiff University: £11,762.00
Start date: 01/03/2019
End date: 31/12/2020